Core Viewpoint - Xixiangfeng Group (02473) has seen a stock increase of over 6%, currently trading at 8.3 HKD, with a transaction volume of 37.2169 million HKD, following the announcement of a strategic cooperation agreement with New Stone Technology [1] Group 1 - The strategic cooperation agreement involves collaboration in areas such as autonomous vehicle procurement, road rights development, operational services, and market promotion [1] - The advancement of artificial intelligence has led to deeper penetration of unmanned technology into traditional industries, with gradual commercialization in specific scenarios [1] - The company plans to leverage its nationwide self-operated network and rich experience in vehicle operation and management to gradually expand its unmanned vehicle business [1] Group 2 - The board believes that the partnership with New Stone Technology will effectively combine its advantages in autonomous vehicle technology and product development, facilitating the smooth development of the company's unmanned vehicle business [1] - This strategic move is expected to diversify the company's business and positively impact its financial condition [1]

Core Viewpoint - The company, Xixiangfeng Group, has seen a stock increase of over 6% following the announcement of a strategic cooperation agreement with New Stone Technology, focusing on the development of autonomous vehicle operations and services [1] Group 1: Company Developments - Xixiangfeng Group's stock rose by 6.27%, reaching HKD 8.3, with a trading volume of HKD 37.2169 million [1] - The company’s wholly-owned subsidiary, Xixiangfeng Financing Leasing Group, signed a strategic cooperation agreement with New Stone Technology, which will involve collaboration in areas such as autonomous vehicle procurement, road rights development, operational services, and market promotion [1] Group 2: Industry Trends - The advancement of artificial intelligence is leading to deeper penetration of automation technologies into traditional industries, with commercial applications in specific scenarios gradually unfolding [1] - The company plans to leverage its nationwide self-operated network and extensive experience in vehicle operation and management to gradually expand its autonomous vehicle business [1] Group 3: Financial Impact - The board believes that the strategic partnership with New Stone Technology will effectively combine its technological and product development advantages, promoting the smooth development of the company's autonomous vehicle business and diversifying its operations, which is expected to have a positive impact on the company's financial status [1]

呈交日期: 2026年1月6日 I. 法定/註冊股本變動 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 喜相逢集團控股有限公司 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02473 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 12,000,000,000 | HKD | 0.003333333333 | HKD | | 40,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 12,000,000,000 | HKD | 0.003333333333 | HKD | | 40,000,000 | ...

Company News - Emperor Capital (00717.HK) reported total revenue of approximately HKD 730 million for the year ending September 30, 2025, representing a year-on-year increase of 37.3%. Net profit reached approximately HKD 147 million, up 121.4% year-on-year [2] - New Special Energy (01799.HK) plans to sell a 79.92% stake in Xinjiang Wind Power New Energy Partnership for approximately HKD 1.337 billion to facilitate a REITs issuance [2] - Bay Area Development (00737.HK) signed a construction contract for the Shenzhen section with a contract value of RMB 1.448 billion [2] - Weichai Power (03393.HK) won a bid for the Brazil CPFL project with a contract amount exceeding HKD 80 million [3] - WuXi AppTec (02359.HK) invested approximately EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [3] - Joy Spreader Group (02473.HK) established a long-term strategic cooperation with New Stone Technology in areas such as autonomous vehicle procurement and market promotion [3] - Fosun Pharma (02196.HK) signed a cooperation and option agreement with Clavis Bio to jointly advance preclinical development of selected target compounds [3] - CSPC Pharmaceutical Group (01093.HK) reported top-line analysis data from the Phase III clinical trial of its drug, Truxima [3] - Yihai International (01662.HK) announced a strategic cooperation between Trio AI and HGC [4] Financing and Buyback Activities - Zhi Yuan Holdings (00990.HK) plans to issue a total of 515 million new shares at a discount of approximately 1.4%, aiming to raise about HKD 355.3 million [5] - Tencent Holdings (00700.HK) repurchased 1.055 million shares for HKD 636 million, with buyback prices ranging from HKD 599.5 to HKD 605.5 [5] - Xiaomi Group-W (01810.HK) repurchased 3.75 million shares for HKD 151 million, with buyback prices between HKD 40.12 and HKD 40.24 [6] - COSCO Shipping Holdings (01919.HK) repurchased 5.9 million shares for HKD 80.6 million, with buyback prices from HKD 13.52 to HKD 13.76 [7] - Kuaishou-W (01024.HK) repurchased 1.235 million shares for HKD 80.2 million, with buyback prices ranging from HKD 64.35 to HKD 65.60 [7] - Geely Automobile (00175.HK) repurchased 1.908 million shares for HKD 31.8 million, with buyback prices between HKD 16.26 and HKD 16.8 [8]

Core Viewpoint - The strategic cooperation agreement between 喜相逢集团 and 新石器 focuses on long-term collaboration in areas such as autonomous vehicle procurement, road rights development, operational services, and market promotion [1][2] Group 1: Strategic Cooperation Details - 喜相逢集团 will procure, lease, or operate autonomous vehicle products from 新石器 and engage in deep business collaboration in specified regions [1] - 喜相逢集团 will be responsible for road rights development, testing, and operational permit applications in designated cities, with 新石器 providing technical support [1] - 新石器 will offer full lifecycle operational maintenance, lifetime software services, and specialized insurance support to 喜相逢集团 [1] - 新石器 grants 喜相逢集团 exclusive distribution rights for three years in cities where road rights are successfully obtained and maintained [1] Group 2: Industry Context and Impact - The advancement of artificial intelligence has led to deeper penetration of unmanned technology into traditional industries, with commercial applications gradually unfolding in specific scenarios [2] - The company plans to leverage its nationwide self-operated network and rich experience in vehicle operation and management to gradually expand its unmanned vehicle business [2] - The board believes that the strategic partnership with 新石器 will effectively combine its advantages in autonomous vehicle technology and product development, promoting the smooth development of the unmanned vehicle business and diversifying the company's operations, which will positively impact its financial condition [2]

Core Viewpoint - The company has entered into a strategic cooperation agreement with New Stone Technology, focusing on the procurement and operation of unmanned vehicles, road rights development, operational services, and market promotion, which is expected to enhance its business diversification and positively impact its financial status [1][2]. Group 1: Strategic Cooperation Details - The agreement includes deep cooperation in unmanned vehicle procurement and operation, where the company will purchase, lease, or operate unmanned vehicle products from New Stone [1]. - The company will be responsible for road rights development, testing, and operational license applications in designated cities, with New Stone providing technical support [1]. - New Stone will offer full lifecycle operational maintenance, lifelong software services, and specialized insurance support to the company [1]. - The company will receive exclusive distribution rights for three years in cities where it successfully obtains and maintains road rights [1]. Group 2: Industry Context and Impact - The advancement of artificial intelligence has led to deeper penetration of unmanned technology into traditional industries, with commercial applications gradually unfolding in specific scenarios [2]. - The company plans to leverage its nationwide self-operated network and extensive experience in vehicle operation and management to gradually expand its unmanned vehicle business [2]. - The board believes that the strategic cooperation with New Stone will effectively combine its technological advantages, facilitating the smooth development of the unmanned vehicle business and broadening the company's business diversification [2].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並表明概不就因本公告全部或任何部分內容而產生或依賴該等內 容而引致的任何損失承擔任何責任。 XXF GROUP HOLDINGS LIMITED 喜相逢集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2473） 本公告乃由喜相逢集團控股有限公司（「本公司」，連同其附屬公司統稱「本集團」） 自願作出，以向本公司股東及潛在投資者提供本集團最新業務發展的詳情。 本公司董事（「董事」）會（「董事會」）欣然宣佈，於2025年12月18日，本公司之間 接全資附屬公司喜相逢融資租賃集團有限公司（「喜相逢集團」）與新石器慧通（北 京）科技有限公司（「新石器」）簽訂戰略合作協議（「該協議」），內容有關雙方在無 人車採購、路權開發、運營服務、市場推廣等領域建立長期戰略合作關係（「該合 作」）。 根據該協議，喜相逢集團與新石器將圍繞以下方向開展深度合作： 具體合作項目的實施細節將由喜相逢集團與新石器另行簽訂的協議予以明確。 1 1. 無人車採購與運營合作：喜相逢集團將向新石器採購、租賃或運營其無人車 產品， ...

Major Events - Chuangsheng Group-B (06628) announced updated efficacy data for osemitamab triple therapy as a first-line treatment for gastric or gastroesophageal junction adenocarcinoma at ESMO Asia [1] - Strength Development (01277) plans to acquire 100% equity of Taiyuan Shidi for approximately 384 million yuan and acquire Dongzhimen property for a total of 86.33 million yuan [1] - Innovent Biologics (01801) completed a global strategic collaboration with Takeda Pharmaceutical and issued 6.9138 million shares under general authorization [1] - Ascentage Pharma-B (06855) received FDA and EMA approval for global registration of a Phase III clinical trial for Nilotinib as a first-line treatment for Ph+ ALL [1] - Baiao Saitou-B (02315) announced that its business partner IDEAYA received IND approval from the FDA for IDE034 [1] - Jinfang Pharmaceutical-B (02595) initiated a registration clinical trial for GFH375, the world's first oral KRAS G12D inhibitor in a controlled chemotherapy Phase III study [1] - Xixiangfeng Group (02473) signed a business cooperation agreement with Hello Car Rental to develop car rental services in designated cities under a "co-branded store" model [1] - International Commercial Settlement (00147) signed a computer chip sales agreement with Hong Kong Antarctic Light to seize growth opportunities in the IC chip market [1] - CSPC Pharmaceutical Group (01093) received clinical trial approval in the U.S. for a GLP-1/GIP receptor dual agonist injection [1] - MIRXES-B (02629) plans to collaborate with Crystal Technology to build an AI-enabled integrated "diagnosis and treatment" research and industrialization platform [1] - Zhengtong Automobile (01728) intends to invest approximately 816 million yuan to acquire Xiamen Xinda 4S dealership and automotive sales and export business [1] - Guorui Life (00108) plans to acquire 78.3% of Beijing Chunyu Tianxia Software for 269 million yuan [1] - Innovent Biologics (01801) successfully included seven innovative products (including new indications) in the 2025 National Medical Insurance Drug List [1] - Peijia Medical-B (09996) had its registration application for the TaurusNXT® "non-aldehyde cross-linked" transcatheter aortic valve replacement system accepted by the National Medical Products Administration [1] - Fosun Pharma (02196) had new drugs included in the National Medical Insurance Directory and commercial insurance innovative drug directory [1] - Junshi Biosciences (01877) had Tuoyi® new indications and Junshida® included in the National Medical Insurance Directory [1] - Valiant Biotech-B (09887) presented clinical data for LBL-034 at the 67th ASH Annual Meeting [1] - Canfite BioPharma (09926) had all approved indications for five marketed drugs successfully included in the latest National Medical Insurance Drug List [1] - Fuhong Hanlin (02696) had Fuzhuoning® (Citrus Acid Vovizili Capsules) included in the National Medical Insurance Drug List [1] - Green Leaf Pharmaceutical (02186) successfully included five new products in the 2025 National Medical Insurance Drug List or commercial insurance innovative drug directory [1] - Yinnuo Pharmaceutical-B (02591) had its core products included in the National Medical Insurance Drug List [1] Operating Performance - Poly Real Estate Group (00119) reported a contract sales amount of approximately 47.7 billion yuan for the first 11 months, a year-on-year decrease of 8.45% [2] - GAC Group (02238) reported November automobile sales of approximately 179,700 units, a year-on-year decline of 9.72% [2] - Xiehe New Energy (00182) reported an equity power generation of 697.23 GWh in November, a year-on-year increase of 7.77% [2]

Core Viewpoint - The partnership between 喜相逢集团 (Xiangxiang Group) and 哈啰租车 (Hello Car Rental) aims to enhance the car rental business through a co-branded store model in designated cities in China, leveraging both companies' strengths to improve user experience and operational efficiency [1][2]. Group 1: Partnership Details - 喜相逢集团's indirect wholly-owned subsidiary, 喜相逢融资租赁集团有限公司, signed a business cooperation agreement with 哈啰租车 on December 5, 2025 [1]. - The collaboration will initially launch in ten cities, including Hangzhou, Hefei, Wuhan, Guiyang, Xi'an, Nanjing, Nanning, Nanchang, Changsha, and Zhengzhou [1]. - The co-branded stores will integrate both "哈啰租车" and "喜相逢" brand images, combining online and offline resources [1]. Group 2: Strategic Implications - The board believes that the partnership will combine the operational experience and offline vehicle resources of 喜相逢集团 with the online platform traffic advantages of 哈啰租车 [2]. - This collaboration aligns with 喜相逢集团's strategic plan to continuously develop automotive-related services [2]. - The partnership is expected to positively impact the future business development and financial status of 喜相逢集团 [2].

Core Insights - 喜相逢集团 has signed a business cooperation agreement with 哈罗租车 to launch a joint car rental business in designated cities in China [1] - The initial plan includes opening joint stores in ten cities, enhancing user experience and operational efficiency through resource integration [1] - The collaboration aims to leverage 喜相逢集团's operational experience and 哈罗租车's online platform advantages, which is expected to positively impact the company's future business development and financial status [1] Company Overview - 喜相逢集团's indirect wholly-owned subsidiary, 喜相逢融资租赁集团有限公司, is involved in the agreement with 哈罗租车 [1] - 哈罗租车 is a leading car rental service platform under the mobile travel platform 哈罗出行, providing standardized online car rental services [1] Strategic Implications - The partnership aligns with 喜相逢集团's strategic planning for the continuous development of automotive-related services [1] - The collaboration is anticipated to enhance asset operational efficiency and user coverage scale for 喜相逢集团 [1] Financial Details - 喜相逢集团 has entered into a 48-month sale and leaseback contract with a total rental fee of 6.442 million yuan [2]